Gardasil news from FiercePharma
NewsFDA grants Gardasil two new indications
Some good news for Merck's Gardasil: The FDA says the human papillomavirus vaccine is approved for prevention of vulvar and vaginal cancers, in addition to its current use as a cervical cancer shot.... Read more...
Analyst gloomy on Merck trends
An influential pharma analyst downgraded Merck shares, saying they've hit their price ceiling. Why? The reasons can be summed up in four drugs: Singulair, Gardasil, taranabant, and Vytorin. Sanford... Read more...
Gardasil "remarkably safe," despite anaphylaxis
Gardasil is "remarkably safe," according to a new study by Australian researchers published in the Canadian Medical Association Journal, even though the study found that the receiving the vaccine... Read more...
Pfizer, Merck go for indirect ads
The new trend in drug marketing isn't drug marketing at all. New commercials from Pfizer and Sanofi-Aventis, plus what can only be called a "jewelry campaign" from Merck, show that pharma companies... Read more...
Is Gardasil worth the cost?
Are HPV vaccines worth the cost? A study in the New England Journal of Medicine concludes that they aren't--at least not for women over 18. They'll only be cost-effective, the resesarchers decided,... Read more...
Will Gardasil special help Merck?
Merck isn't having the best week in the news (and is the subject of quite a few pharma jokes), but... Read more...
Gardasil side effects prompt CDC study
Merck is likely quite displeased with the barrage of negative press about its... Read more...
Gardasil: Some good news for Merck
But here's some news that Merck can really use: FDA and CDC gave its Gardasil a (re)seal of approval, saying the vaccine is safe and effective for the prevention of some of the strains of genital... Read more...
Flat Gardasil sales trigger Merck sell-off
A one-two punch for Merck's Gardasil yesterday: First, a market analyst downgraded the company's stock largely because of flat sales of the human papilloma virus vaccine. Gardasil sales have fallen... Read more...
One up, two down for Merck's vaccines
One out of three ain't bad? Out of a trio of Merck vaccine news today, one story was a clear thumbs-up for the company: Its
| Press ReleasesFDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal CancersFDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers September 12, 2008 The U.S. Food and Drug Administration today announced the approval of the vaccine Read more >> PRESS RELEASE: Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors Merck Products Named Best Biotechnology Product and Best Pharmaceutical Agent Former Merck CEO P. Roy Vagelos, M.D., Receives Pro Bono Read more >> |
Get more Gardasil coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
